Abstract:Ageing is a conserved and unavoidable biological process characterized by progressive decline of physiological functions with time. Despite constituting the greatest risk factor for most human diseases, little is known about the molecular mechanisms driving the ageing process. More than 170 chemical RNA modifications, also known as the epitranscriptome, decorate eukaryotic coding and non-coding RNAs and have emerged as novel regulators of RNA metabolism, modulating RNA stability, translation, splicing or non-coding RNA processing. Studies on short-lived organisms such as yeast or worms connect mutations on RNA modifying enzymes with lifespan changes, and dysregulation of the epitranscriptome has been linked to age-related diseases and ageing hallmarks themselves in mammals. Moreover, transcriptome-wide analyses are starting to reveal changes in messenger RNA modifications in neurodegenerative diseases and in the expression of some RNA modifiers with age. These studies are starting to put the focus on the epitranscriptome as a potential novel regulator of ageing and lifespan, and open new avenues for the identification of targets to treat age-related diseases. In this review, we discuss the connection between RNA modifications and the enzymatic machinery regulating their deposition in coding and non-coding RNAs, and ageing and hypothesize about the potential role of RNA modifications in the regulation of other ncRNAs playing a key role in ageing, such as transposable elements and tRNA fragments. Finally, we reanalyze available datasets of mouse tissues during ageing and report a wide transcriptional dysregulation of proteins involved in the deposition, removal or decoding of several of the best-known RNA modifications.

Regulatory RNA-binding proteins in senescence.

Regulatory RNA binding proteins contribute to the transcriptome-wide splicing alterations in human cellular senescence.

Dysregulated RNA processing and metabolism: a new hallmark of ageing and provocation for cellular senescence

Regulation and roles of RNA modifications in aging‐related diseases

Regulatory RNAs in immunosenescence

Epigenetic Regulation of Cellular Senescence

Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation

RNA-binding proteins and post-transcriptional gene regulation

A review on the role of RNA methylation in aging-related diseases

RNA-binding proteins involved in post-transcriptional regulation in bacteria

Auto-regulatory feedback by RNA-binding proteins

Mechanisms and Regulation of Cellular Senescence

Epitranscriptomics: new players in an old game.

SATB1, senescence and senescence‐related diseases

Roles of long noncoding RNAs in aging and aging complications

Mechanistic Dissection of RNA-Binding Proteins in Regulated Gene Expression at Chromatin Levels

Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence

RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease

Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability